Protein A resins market outlook: Biopharmaceutical sector to be the dominant end-user
Publisher : Fractovia | Published Date : 2017-03-03Request Sample
The surging demand for protein A resins market is expected to evolve more over the coming years owing to the increasing research on monoclonal antibodies. With the rising prevalence of chronic diseases like rheumatoid arthritis, cancer, etc., the extensive use of monoclonal antibodies in these treatments, is growing rapidly. The Recent revolution in protein separation and purification techniques which include chromatography, precipitation, and filtration, is also expected to drive the protein A resin industry globally. According to Global Market Insights, Inc.,” Protein A resins market worth over USD 440 million in 2015, is projected to grow at a CAGR of 8.4% over the period 2016-2024 “. Accelerating demand for biosimilars along with regulatory norms is favoring research activities, thereby propelling the overall protein A resins industry.
Protein A resins industry mainly finds its application in two sectors- antibody purification, and immunoprecipitation. Protein A resins market size in antibody purification application is slated to witness a substantial growth in future, with an expected revenue share of USD 700 million by 2024, driven by the increasing diagnostic application of recombinant and monoclonal antibodies.
Japan Protein A Resin Market size, by matrix type, 2012-2024 (USD Million)
Immunoprecipitation industry held a share of 20% of the overall protein A resins market in 2015, and is anticipated to grow an annual rate of 8% over the period 2016- 2024.
Biopharmaceutical firms and Contract research organizations are the major end users of protein A resins industry. Biopharmaceutical companies accounted for a share of 75% of protein A resins market in 2015, and is expected to surpass USD 680 million by 2024.
Protein A resins market is also projected to grow significantly owing to its increasing adaption by Contract research organizations (CROs). It is estimated to have a revenue share of USD 130 million at an annual growth rate of 8.1% over the period 2016 to 2024.
Considering the global outlook, U.S. protein A resins industry covered 85% of the total share in 2015 and is expected to continue its regional dominance due to the increasing clinical infrastructural development across this region.
Asia Pacific Protein A resins market is anticipated to show a striking annual growth rate of 8.5% over the coming seven years with a major contribution from Japan as it accounted for almost 40% of the total share in 2015. Driven by the stringent government regulations for dynamic healthcare infrastructure development along with easy availability of capable professionals, Japan protein A resin industry is expected to exceed a revenue worth 78 million by 2024.
Antibody purification market in India is poised to show a steady growth in future, driven by factors such as increasing research on monoclonal antibodies and growing prevalence of cancer. Spain protein A resins industry is also foreseen to show a substantial growth over the forecast time frame, owing to the country’s rising demand for biosimilar products. Mexico is projected to witness a modest growth in terms of market share and is forecast to attain a CAGR of 8% over the period 2016-2024.
Prominent industry players include GE Healthcare, GenScript, Repligen, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Tosoh Bioscience, Thermo Fisher Scientific, Novasep, Bio-Rad Laboratories, Expedeon, and Agarose Bead Technologies.
